TβRIII independently binds type i and type II TGF-β receptors to inhibit TGF-β signaling

Molecular Biology of the Cell

Volumn 26, Issue 19, 2015, Pages 3535-3545

  Tazat, Keren ^a   Hector Greene, Melissa ^b   Blobe, Gerard C ^b,c   Henis, Yoav I ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Department of Medicine ^*  (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; SCAFFOLD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; CROSS LINKING REAGENT; PROTEIN BINDING; PROTEIN SERINE THREONINE KINASE; PROTEOGLYCAN; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; DIFFUSION; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; IMMOBILIZATION; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMISTRY; HUMAN; METABOLISM;

CELLS, CULTURED; CROSS-LINKING REAGENTS; HUMANS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84943147193     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E15-04-0203     Document Type: Article

References (57)

1. Bernabeu C, Lopez-Novoa JM, Quintanilla M (2009). The emerging role of TGF-b superfamily coreceptors in cancer. Biochim Biophys Acta 1792, 954-973.
2. Blobe GC, Liu X, Fang SJ, How T, Lodish HF (2001a ). A novel mechanism for regulating transforming growth factor b (TGF-b) signaling. Functional modulation of type III TGF-b receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem 276, 39608-39617.
3. Blobe GC, Schiemann WP, Pepin MC, Beauchemin M, Moustakas A, Lodish HF, O'Connor-McCourt MD (2001b ). Functional roles for the cytoplasmic domain of the type III transforming growth factor b re ceptor in regulating transforming growth factor b signaling. J Biol Chem 276, 24627-24637.
4. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC (200 3). Beta-Arrestin 2 mediates endocytosis of type III TGF-b receptor and down-regulation of its signaling. Science 301, 1394-1397.
5. Chen C, Wang XF, Sun L (1997). Expression of growth factor b (TGFb) typ e III receptor restores autocrine TGFb1 activity in human breast cancer MCF-7 cells. J Biol Chem 272, 12862-12867.
6. Chetrit D,Ziv N,Ehrlich M 2009 Dab2 regulates clathrin assembly and cell spreading. Biochem J 418 701-715.
7. Clarke DC, Liu X (2008). Decoding the quantitative nature of TGF-b/Smad signaling. Trends Cell Biol 18, 430-442.
8. Copland JA, Luxon BA, Ajani L, Maity T, Campagnaro E, Guo H, LeGrand SN, Tamboli P, Wood CG (2003). Genomic profiling identifies alterations in TGFb signaling through loss of TGFb receptor expression in human renal cell carcinogenesis and progression. Oncogene 22, 8053-8062.
9. Deheuninck J, Luo K (2009). Ski and SnoN, potent negative regulators of TGF-b signaling. Cell Res 19, 47-57.
10. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM (1998). Direct binding of Smad3 and Smad4 to critical TGF b-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17, 3091-3100.
11. Dong M, How T, Kirkbride KC, Gordon KJ, Lee JD, Hempel N, Kelly P, Moeller BJ, Marks JR, Blobe GC (2007). The type III TGF-b receptor suppresses breast cancer progression. J Clin Invest 117, 206-217.
12. Ehrlich M, Gutman O, Knaus P, Henis YI (2012). Oligomeric interactions of TGF-b and BMP receptors. FEBS Lett 586, 1885-1896.
13. Ehrlich M, Horbelt D, Marom B, Knaus P, Henis YI (2011). Homomeric a nd heteromeric complexes among TGF-b and BMP receptors and their roles in signaling. Cell Signal 23, 1424-1432.
14. Ehrlich M, Shmuely A, Henis YI (2001). A single internalization signal from the di-leucine family is critical for constitutive endocytosis of the type II TGF-b receptor. J Cell Sci 114, 1777-1786.
15. Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG (2002). Betaglycan inhibits TGF-b signaling by preventing type I-type II receptor complex formation: glycosaminoglycan modifications alter betaglycan function. J Biol Chem 277, 823-829.
16. Eisenberg S, Shvartsman DE, Ehrlich M, Henis YI (2006). Clustering of raftassociated proteins in the external membrane leaflet modulates internal leaflet H-Ras diffusion and signaling. Mol Cell Biol 26, 7190-7200.
17. Elderbroom JL, Huang JJ, Gatza CE, Chen J, How T, Starr M, Nixon AB, Blobe GC (2014). Ectodomain shedding of TbRIII is required for TbRIIImediated suppression of TG F-b signaling and breast cancer migration and invasion. Mol Biol Cell 25, 2320-2332.
18. Elliott RL, Blobe GC (2005). Role of transforming growth factor Beta in human cancer. J Clin Oncol 23, 2078-2093.
19. Evan GI, Lewis GK, Ramsay G, Bishop JM (1985). Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 5, 3610-3616.
20. Feng XH, Derynck R (2005). Specificity and versatility in TGF-b signaling through Smads. Annu Rev Cell Dev Biol 21, 659-693.
21. Finger EC, Lee NY, You HJ, Blobe GC (2008). Endocytosis of the type III TGF-b recepto r through the clathrin-independent/lipid raft pathway regulates TGF-b signaling and receptor downregulation. J Biol Chem 283, 34808-34818.
22. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K ( 1993). Cloning of a TGFb type I receptor that forms a heteromeric complex with the TGFb type II receptor. Cell 75, 681-692.
23. Gatza CE, Holtzhausen A, Kirkbride KC, Morton A, Gatza ML, Datto MB, B lobe GC (2011). Type III TGF-beta receptor enhances colon cancer cell migration and anchorage-independent growth. Neoplasia 13, 758-770.
24. Gatza CE, Oh SY, Blobe GC (2010). Roles for the type III TGF-b receptor in human cancer. Cell Signal 22, 1163-1174.
25. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P (2000). Bone morphogenetic protein receptor complexes on the surface of live cells: A new oligomerization mode for Serine/Threonine kinase receptors. Mol Biol Cell 11, 1023-1035.
26. Gilboa L, Wells RG, Lodish HF, Henis YI (1998). Oligomeric structure of type I and type II TGF-b receptors : homo-dimers form in the ER and persist at the plasma membrane. J Cell Biol 140, 767-777.
27. Gordon KJ,Blobe GC 2008 Role of transforming growth factor-b superfamily signaling pathways in human disease Biochim Biophys Acta 1782, 197-228
28. Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC (2008). Loss of type III transforming growth factor b receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Carcinogenesis 29, 252-262.
29. Groppe J, Hinck CS, Samavarchi-Tehrani P, Zubieta C, Schuermann JP, Taylor AB, Schwarz PM, Wrana JL, Hinck AP (2008). Coope rative assembly of TGF-b superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol Cell 29, 157-168.
30. Heldin CH, Landstrom M, Moustakas A (2009). Mechanism of TGF-b signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21, 166-176.
31. Hempel N, How T, Dong M, Murphy SK, Fields TA, Blobe GC (2007). Loss of betaglycan expression in ovarian cancer: role in motility and invasion. Cancer Res 67, 5231-5238.
32. Henis YI, K atzir Z, Shia MA, Lodish HF (1990). Oligomeric structure of the human asialoglycoprotein receptor: nature and stoichiometry of mutual complexes containing H1 and H2 polypeptides assessed by fluorescence photobleaching recovery. J Cel l Biol 111, 1409-1418.
33. Henis YI, Moustakas A, Lin HY, Lodish HF (1994). The types II and III transforming growth factor-b receptors form homo-oligomers. J Cell Biol 126, 139-154.
34. Ji C, Chen Y, McCarthy TL, Centrella M (1999). Cloning the promoter for transforming growth factor-beta type III receptor. Basal and conditional expression in fetal rat osteoblasts. J Biol Chem 274, 30487-30494.
35. Lambert KE, Huang H, Mythreye K, Blobe GC (2011). The type III transforming growth factor-b receptor inhibits proliferation, migration, and adhesion in human myeloma cells. Mol Biol Cell 22, 1463-1472.
36. Lee JD, Hempel N, Lee NY, Blobe GC (2010). The type III TGF-b receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-b signaling. Carcinogenesis 31, 175-183.
37. Lin HY, Wang X-F, Ng-Eaton E, Weinberg RA, Lodish HF (1992). Expression cloning of the TGF-b type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.
38. López-Casillas F, Pa yne HM, Andres JL, Massague J (1994). Betaglycan can act as a dual modulator of TGF-b access to signaling receptors: mapping of ligand binding and GAG attachment sites. J Cell Biol 124, 557-568.
39. López-Casil las F, Wrana JL, Massague J (1993). Betaglycan presents ligand to the TGF-b signalling receptor. Cell 73, 1435-1444.
40. Marom B, Heining E, Knaus P, Henis YI (2011). Formation of stable homome ric and transient heteromeric bone morphogenetic protein (BMP) receptor complexes regulates Smad protein signaling. J Biol Chem 286, 19287-19296.
41. Massague J (1998). TGF-b signal transduction. Annu Rev Biochem 67, 753-791.
42. Massague J (2012). TGFb signalling in context. Nat Rev Mol Cell Biol 13, 616-630.
43. Moustakas A, Heldin CH (2009). The regulation of TGFb signal transduction. Development 136, 3699-3714.
44. Mythreye K, Blobe GC (2009). The type III TGF-b receptor regulates epithelial and can cer cell migration through b-Arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci USA 106, 8221-8226.
45. Petersen NO, Felder S, Elson EL (1986). Measurement of lateral diffusion by fluorescence photobleaching recovery. In: Handbook of Experimental Immunology, ed. DM Weir, LA Herzenberg, CC Blackwell, and LA Herzenberg, Edinburgh: Blackwell Scientific, 24.21-24.23.
46. Radaev S, Zou Z, Huang T, Lafer EM, Hinck AP, Sun PD (2010). Ternary complex of transforming growth factor-b1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily. J Biol Chem 285, 14806-14814.
47. Rechtman MM, Nakaryakov A, Shapira KE, Ehrlich M, Henis YI (2009). Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-b receptors. J Biol Chem 284, 7843-7852.
48. Schmierer B,Hill CS 2007 TGFb-SMAD signal transduction: molecular specificity and functional flexibility Nat Rev Mol Cell Biol 8 970-982.
49. Segarini PR (1990). Cell type specificity of TGF-b binding. Ann NY Acad Sci 593, 73-90.
50. Shapira KE, Gross A, Ehrlich M, Henis YI (2012). Coated pit-mediated endocytosis of the type I transforming growth factor-b (TGF-b) receptor depends on a di-leucine family signa l and is not required for signaling. J Biol Chem 287, 26876-26889.
51. Shi Y, Massague J (2003). Mechanisms of TGF-b signaling from cell membrane to the nucleus. Cell 113, 685-700.
52. Shvartsman DE, Kotler M, Tall RD, Roth MG, Henis YI (2003). Differentlyanchored influenza hemagglutinin mutants display distinct interaction dynamics with mutual rafts. J Cell Biol 163, 879-888.
53. Sun L, Chen C (1997). Expression of transforming growth factor b type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells. J Biol Chem 272, 25367-25372.
54. Turley RS, Finger EC, Hem pel N, How T, Fields TA, Blobe GC (2007). The type III transforming growth factor-b receptor as a novel tumor suppressor gene in prostate cancer. Cancer Res 67, 1090-1098.
55. You HJ, Bruinsma MW, H ow T, Ostrander JH, Blobe GC (2007). The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis 28, 2491-2500.
56. You HJ, How T, Blobe GC (2009). The type III transforming growth factor-b receptor negatively regulates nuclear factor kappa B signaling through its interaction with b-Arrestin2. Carcinogenesis 30, 1281-1287.
57. Zhang YE (2009). Non-Smad pathways in TGF-b signaling. Cell Res 19, 128-139.